EP 1370289 A2 20031217 - METHOD FOR PRODUCING A VACCINE CONTAINING AUTOLOGOUS ANTIBODIES
Title (en)
METHOD FOR PRODUCING A VACCINE CONTAINING AUTOLOGOUS ANTIBODIES
Title (de)
VERFAHREN ZUR HERSTELLUNG EINES AUTOLOGEN ANTIKÖRPERS ENTHALTENDEN IMPFSTOFFES
Title (fr)
PROCEDE DE PRODUCTION D'UN VACCIN CONTENANT DES ANTICORPS AUTOLOGUES
Publication
Application
Priority
- AT 0200091 W 20020320
- AT 4702001 A 20010323
Abstract (en)
[origin: WO02080966A2] The invention relates to a method for producing a vaccine, which contains autologous antibodies, characterized by the following steps: preparing a liquid that contains antibodies from a body fluid containing autologous antibodies or from autologous cell preparations or tissue preparations; treating the liquid that contains antibodies with a solid support, on which ligands are immobilized that bond to a defined group of antibodies, with the stipulation that the ligands used are not antibodies or fragments thereof with the same idiotype, directed against tumor-associated antigens; obtaining the antibodies that bond to the ligands, and; processing the obtained antibodies to form an autologous vaccine, which contains an efficient amount of antibodies ranging from several micrograms to one gram.
IPC 1-7
IPC 8 full level
A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 39/395 (2006.01); A61P 3/10 (2006.01); A61P 15/06 (2006.01); A61P 21/04 (2006.01); A61P 25/00 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); A61P 37/08 (2006.01); C07K 16/06 (2006.01); C07K 16/42 (2006.01)
CPC (source: EP US)
A61P 3/10 (2017.12 - EP); A61P 15/06 (2017.12 - EP); A61P 21/04 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/08 (2017.12 - EP); C07K 16/06 (2013.01 - EP US); C07K 16/065 (2013.01 - EP US); C07K 16/42 (2013.01 - EP US); A61K 2039/505 (2013.01 - EP US)
Citation (search report)
See references of WO 02080966A2
Citation (examination)
BERGENBRANT ET AL: "Modulation of anti-idiotype immune response by immunization with the autologous M-component protein in multiple myeloma patients", BRITISH JOURNAL OF HAEMATOLOGY, vol. 92, 1996, pages 840 - 846
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02080966 A2 20021017; WO 02080966 A3 20030912; WO 02080966 A8 20030123; WO 02080966 A8 20040115; AT 410636 B 20030625; AT A4702001 A 20021115; BR 0208641 A 20040309; CA 2441499 A1 20021017; CN 1522155 A 20040818; EP 1370289 A2 20031217; HU P0303638 A2 20040128; HU P0303638 A3 20041028; JP 2004524369 A 20040812; MX PA03008587 A 20040630; NO 20034145 D0 20030917; NO 20034145 L 20031107; PL 363720 A1 20041129; SK 11732003 A3 20040302; US 2004191242 A1 20040930
DOCDB simple family (application)
AT 0200091 W 20020320; AT 4702001 A 20010323; BR 0208641 A 20020320; CA 2441499 A 20020320; CN 02808838 A 20020320; EP 02706509 A 20020320; HU P0303638 A 20020320; JP 2002579005 A 20020320; MX PA03008587 A 20020320; NO 20034145 A 20030917; PL 36372002 A 20020320; SK 11732003 A 20020320; US 47287604 A 20040308